Bacc Med-Tech Fund Ii Llc has raised $1.9M over 2 rounds; too few niche peers to rank its valuation yet.
Raised $1.9M across 2 disclosed rounds, last modeled as Seed (a $1.0M–$4.0M round).
Latest round stepped up 1.1× from the prior — scaling.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Issuer-vehicle patternmedium confidence
Bacc Med-Tech Fund Ii Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
10.1 yr record
Peak capital year was 2016 with $2.2M across 3 filings.
Market position
ahead of 40% of Investment Vehicle peers
Capital scale is ahead of 40% of Investment Vehicle peers; modeled value is above 40% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
Legal name looks like an issuer vehicle rather than a product company.
No clearly named CEO/founder/principal role in the public records surfaced here.
No verified homepage on the profile yet.
Capital program peaked in 2016: $2.2M across 3 filings.
Largest single filing was $1.0M on 2018-09-07.
Filing rows sum to $4.2M, while canonical raised total is $1.9M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
Read this less like a startup funding journey and more like a capital-raising program.
Stage-based valuation and peer labels have lower applicability for this pattern.
The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Canonical filtering should be tightened before using row-level totals for diligence.
Leadership
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Where it sits in Investment Vehicle
Bacc Med-Tech Fund Ii Llc is one of 1793 Investment Vehicle companies tracked from MANKATO. By capital raised it ranks mid-pack (ahead of 40% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
US
Jurisdiction
Rule 506(b)
Reg D exemption
17
Investors (latest)
2016
Year incorporated
2018-09-07
First sale
Amount raised vs valuation, by round
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
Amount raised · realModeled valuation · estCumulative funded · real
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Financing ladder & sequence gaps
Pre-Seed$769K · 2016
Pre-Seed extension$869K · 2016
Pre-Seed extension$555K · 2016
Seed$1.0M · 2018
Bridge · Seed-stage$476K · 2018smaller follow-on
Bridge · Seed-stage$505K · 2018smaller follow-on
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Modeled valuation trajectory
$18.7M
Base estimate est.
$904K
Conservative case
$146.5M
Upside case
$5.0M
Modeled post-money
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
40%
Survival probability
18% low · 62% high
1.45×/yr
Annual markup
1.90×/yr upside case
6.0 yr
Elapsed time used
7.8 yr actual, capped for stale marks
general
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
5 mo
Avg between rounds
$839K/yr
Capital velocity
10.1 yr
On record since
2016
First round
6
Rounds on file
How it compares to the market
Benchmarked against 1793 companies in Investment Vehicle. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Total raised — vs sector median (real $, all stages)▼ 0.6× of median
This company$1.9M
Sector median$3.2M
Latest round — vs other Seed rounds in sector (real $, this stage)▼ 0.3× of median
This company$505K
Sector median$2.0M
Modeled value — vs sector median (estimate, all stages)▼ 0.7× of median
This company$18.7M
Sector median$25.2M
Raised more than 40% of sector peers (real $). Modeled value above 40% of peers (estimate).
Full financing history
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
Stage
Amount · real
Announced
Post-money · est
Value · est
Conf.
Pre-Seed
$769K
2016-06-14
$4.3M
$17.8M
90%
Pre-Seed
$869K
2016-06-14
$4.8M
$20.1M
90%
Pre-Seed
$555K
2016-06-14
$3.1M
$12.8M
85%
Seed
$1.0M
2018-09-07
$5.0M
$18.7M
90%
Pre-Seed
$476K
2018-09-07
$2.6M
$11.0M
90%
Pre-Seed
$505K
2018-09-07
$2.8M
$11.7M
90%
What happened at each round
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Pre-Seed$769K2016-06-14
First recorded raise — entered as Pre-Seed.
15 investors on this round.
Pre-Seed$869K2016-06-14
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
16 investors on this round.
Pre-Seed$555K2016-06-14
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 1.6× smaller than the prior — bridge or down round.
9 investors on this round.
Seed$1.0M2018-09-07
Raised 27 mo later.
Round 1.8× larger than the prior — scaling up.
18 investors on this round.
Pre-Seed$476K2018-09-07
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 2.1× smaller than the prior — bridge or down round.
12 investors on this round.
Pre-Seed$505K2018-09-07
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
17 investors on this round.
Intelligence
2019 ~Q1
Modeled next raise · ~5mo cadence
$536K
Modeled next size est.range $505K–$858K
1.1×
Last step-up
$839K/yr
Capital velocity
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Key people & operators
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
Bacc Med-Tech Fund Ii Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
United States
Country of record
US
Jurisdiction
1678091
SEC CIK
2016
Incorporated
Similar companies
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
How much funding has Bacc Med-Tech Fund Ii Llc raised?
Bacc Med-Tech Fund Ii Llc has raised approximately $1.9M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Bacc Med-Tech Fund Ii Llc's estimated valuation?
Provath's modeled valuation for Bacc Med-Tech Fund Ii Llc is approximately $18.7M (modeled range $904K–$146.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Bacc Med-Tech Fund Ii Llc at?
Bacc Med-Tech Fund Ii Llc's latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Sep 07.
What does Bacc Med-Tech Fund Ii Llc do and where is it based?
Bacc Med-Tech Fund Ii Llc operates in the Investment Vehicle sector, based in MANKATO.
Explore related
See where Bacc Med-Tech Fund Ii Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Bacc Med-Tech Fund Ii Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.